Reaction Details | |||
---|---|---|---|
![]() | Report a problem with these data | ||
Target | Oxysterols receptor LXR-beta | ||
Ligand | BDBM44706 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based dose response screening assay to identify agonists of the Liver-X-Receptor (LXR) | ||
EC50 | 67533±n/a nM | ||
Citation | ![]() | ||
More Info.: | Get all data from this article, Solution Info, Assay Method | ||
Oxysterols receptor LXR-beta | |||
Name: | Oxysterols receptor LXR-beta | ||
Synonyms: | LXRB | Liver X receptor beta (NR1H2) | Liver X, LXR beta | NER | NR1H2 | NR1H2_HUMAN | Nuclear receptor NER | UNR | Ubiquitously-expressed nuclear receptor | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 50978.79 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P55055 | ||
Residue: | 460 | ||
Sequence: |
| ||
BDBM44706 | |||
n/a | |||
Name | BDBM44706 | ||
Synonyms: | (4-methylcyclohexyl) 3-methyl-4-oxidanylidene-1,5,6,7-tetrahydroindole-2-carboxylate | (4-methylcyclohexyl) 3-methyl-4-oxo-1,5,6,7-tetrahydroindole-2-carboxylate | 3-methyl-4-oxo-1,5,6,7-tetrahydroindole-2-carboxylic acid (4-methylcyclohexyl) ester | 4-keto-3-methyl-1,5,6,7-tetrahydroindole-2-carboxylic acid (4-methylcyclohexyl) ester | MLS000116534 | SMR000093504 | cid_2996853 | ||
Type | Small organic molecule | ||
Emp. Form. | C17H23NO3 | ||
Mol. Mass. | 289.3694 | ||
SMILES | CC1CCC(CC1)OC(=O)c1[nH]c2CCCC(=O)c2c1C |(16.57,-1.54,;15.03,-1.54,;14.26,-.21,;12.72,-.21,;11.95,-1.54,;12.72,-2.87,;14.26,-2.87,;10.41,-1.54,;9.64,-.21,;10.41,1.13,;8.1,-.21,;7.2,-1.45,;5.75,-.98,;4.41,-1.75,;3.08,-.98,;3.08,.56,;4.41,1.33,;4.41,2.87,;5.75,.56,;7.2,1.03,;7.68,2.5,)| | ||
Structure | ![]() |